Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease (Q35794132)
Jump to navigation
Jump to search
scientific article published on 20 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease |
scientific article published on 20 June 2011 |
Statements
1 reference
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease (English)
1 reference
David Dingli
1 reference
Angela Dispenzieri
1 reference
Martha Q Lacy
1 reference
Stephen J Russell
1 reference
S Vincent Rajkumar
1 reference
Morie A Gertz
1 reference
Suzanne R Hayman
1 reference
Steven Zeldenrust
1 reference
John A Lust
1 reference
Francis Buadi
1 reference
Shaji Kumar
1 reference
P Leif Bergsagel
1 reference
Craig Reeder
1 reference
Vivek Roy
1 reference
Joseph R Mikhael
1 reference
Philip R Greipp
1 reference
Kristen Detweiler Short
1 reference
Jacob B Allred
1 reference
Kristina Laumann
1 reference
A Keith Stewart
1 reference
Sumithra J Mandrekar
1 reference
20 June 2011
1 reference
1 reference
118
1 reference
11
1 reference
2970-2975
1 reference
Identifiers
1 reference
1 reference
1 reference